Showing results (1941-1950 of 7,775) with videos related to
Sort By:
Pageof 778
Pharmacological Research|December 6, 2022
Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease preventionStanisław Surma, Amirhossein Sahebkar, Maciej BanachPharmacological Research|June 11, 2022
Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean feverFrancesca Marinelli, Chiara Caporilli, Annachiara Titolo, et al.Pharmacological Research|June 12, 2022
Targeting the WASF3 complex to suppress metastasisAmeya J Limaye, Matthew K Whittaker, George N Bendzunas, et al.Pharmacological Research|June 24, 2022
Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramerPaulo A De Oliveira, Estefanía Moreno, Nil Casajuana-Martin, et al.Pharmacological Research|June 24, 2022
Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancyHongye Zou, Yatian Yang, Zhenrui Shi, et al.Pharmacological Research|November 25, 2022
Phenolipid JE improves metabolic profile and inhibits gluconeogenesis via modulating AKT-mediated insulin signaling in STZ-induced diabetic miceGuihua Wang, Jialin Xu, Hang Ma, et al.Pharmacological Research|May 5, 2022
Theranostic nanosystem with supramolecular self-assembly for enhanced reactive oxygen species-mediated apoptosis guided by dual-modality tumor imagingDan Yan, Haili Zhang, Xiao Xu, et al.Pharmacological Research|May 21, 2019
Ivabradine and metoprolol in fixed dose combination: When, why and how to use itV Katsi, G Skalis, M S Kallistratos, et al.Pharmacological Research|May 22, 2019
MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1Xuerong Zhao, Yue Jin, Lei Li, et al.Pharmacological Research|October 9, 2021
A Bayesian network meta-analysis regarding the comparative efficacy of therapeutics for ALK-positive, brain metastatic non-small cell lung cancerBinghao Zhao, Yan Han, Yadong Wang, et al.Pageof 778